Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Toy distraction eases needle fear in young kids

NCT ID NCT07459517

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 14, 2026 · Updated 2 times

Summary

This study looks at whether a musical-moving toy can lower fear and help IV insertion go more smoothly in children ages 4 to 6 who have hard-to-find veins. About 70 kids will be randomly assigned to either get the toy during the procedure or receive standard care. Researchers will measure fear levels, how many attempts are needed, and how long the procedure takes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

68 people

The number who actually took part.

Started

Nov 2024

Finished

Feb 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

4 to 6 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Children aged 4-6 years * Children requiring peripheral intravenous catheterization in the pediatric emergency department * Children with a Difficult Intravenous Access (DIVA) score ≥4 * Children whose parents or legal guardians provide informed consent for participation Exclusion Criteria: * Children with cognitive or developmental disorders that may interfere with fear assessment * Children with visual or hearing impairments preventing interaction with the distraction toy * Children who require urgent or life-saving interventions * Children whose parents decline participation in the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Difficult intravenous access are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Akdeniz University

    Antalya, Dumlupınar, 07058, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.